Medpace Holdings Inc vs iShares US Power Infrastructure ETF — how do they compare? Medpace Holdings Inc trades at $615.82 (market cap $16.82B), while iShares US Power Infrastructure ETF trades at $25.47 (market cap $446.54M). The key difference: Medpace Holdings Inc is far larger — about 37.7× iShares US Power Infrastructure ETF's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, iShares US Power Infrastructure ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and iShares US Power Infrastructure ETF for 14 Days on average.
| MEDP | POWR | |
|---|---|---|
Market Cap | $16.82B | $446.54M |
Volume | 223,093 | 160,852 |
Sector | Health | Sector/Thematic |
52-Week High | $630.19 | $28.22 |
52-Week Low | $393.42 | $23.20 |
Typical Hold Time | 14 Days | 14 Days |
Enterprise Value | $16.44B | — |
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.
MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →iShares U.S. Power Infrastructure ETF seeks exposure to U.S. companies involved in power infrastructure. Its holdings may include electric utilities, transmission and distribution businesses, and electrical equipment providers.
Read more on POWR →